Home > Riviste > The Journal of Cardiovascular Surgery > Fascicoli precedenti > Articles online first > The Journal of Cardiovascular Surgery 2020 Sep 23

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo

 

 

The Journal of Cardiovascular Surgery 2020 Sep 23

DOI: 10.23736/S0021-9509.20.11614-8

Copyright © 2020 EDIZIONI MINERVA MEDICA

lingua: Inglese

Current status on aortic endografts

Vincenzo VENTO 1, 2, 3, Anne LEJAY 1, 2, Salomé KUNTZ 2, Stefano ANCETTI 3, Frédéric HEIM 1, 4, Nabil CHAKFÉ 1, 2, Mauro GARGIULO 3

1 Groupe Européen de Recherche sur les Prothèses Appliquées à la Chirurgie Vasculaire, Strasbourg, France; 2 Department of Vascular Surgery and Kidney Transplantation, University Hospital of Strasbourg, Strasbourg, France; 3 Vascular Surgery, Department of Experimental Diagnostic and Specialty Medicine (DIMES), Policlinico S. Orsola- Malpighi, University of Bologna, Bologna, Italy; 4 Laboratoire de Physique et Mécanique Textile, Université de Haute-Alsace, Mulhouse, France


PDF


Endovascular treatment has become widespread to treat aneurysmal disease, especially located in the aorta. The modern era of abdominal aortic aneurysm repair started between 1986 and 1991, and in the last 30 years, Endovascular Treatment for abdominal aortic aneurysms evolved both due to the development of new materials and devices and the increasing appeal and effectiveness of the endovascular therapy itself. Vascular surgeons are using nowadays different solutions of Endovascular Treatment to treat all the expressions of aortic pathology (aneurysms, dissections and trauma) both in the acute and elective setting. Despite its use in every location of the aorta (the ascending aorta, the aortic arch, the thoracic aorta, thoraco-abdominal aorta, pararenal, iuxtarenal and infrarenal aortic aneurysms and iliac aneurysms), its safety and efficiency, endovascular treatment for aortic aneurysms presents some drawbacks: despite a lower short-term morbi-mortality, reinterventions and long-term patency are higher compared to open repair. In this review, we detail the most used types of endografts according to location, their performances and durability for each device. We conclude by discussing options to overcome ET limitations. Therefore, an obvious question arises: what we need in the future? What can the technological progress gives to physicians to further improve this new way of treating aorta?


KEY WORDS: Aorta; EVAR; TEVAR; Endovascular

inizio pagina